For example, two places research is done here in Ohio, Ohio State and Battelle receive federal funds for research.
According to the latest figures available from the Nation Science Foundation, in 2004 of the 518 million dollars spent on research at OSU, $284.6 million were federal funds, half of that from the National Institute for Health.
Douglas Kniss, a professor of obstetrics and gynecology and biomedical engineering and the senior associate vice president for research at Ohio State:
Only a few universities and a few biotechnology companies have raised private money for embryonic stem cell research in the U.S. So far, however, no new human embryonic stem cell lines have been derived in the U.S. with public or private money since 2001.
Ohio behind other states for stem cell research,http://www.thelantern.com - 5/16/06
Battelle Memorial Institute, according to the Nation Science Foundation in 2003, ranked 6th in independent non-profit institutions for federal R&D funds, receiving 122.8 million, $51.7 million from the Department of Health and Human Services. Battelle also holds contracts for the operation and management of several national laboratories, 41st on the 2005 List of Top 100 Federal Prime Contractors.
Said Stanford Nobel laureate Paul Berg, a critic of the administration: "What many people don't understand is it is not just the money.'' Equipment and laboratory space supported with federal dollars cannot be used for research with the newer stem-cell lines, he said. That's why money directed toward research from California and other states "is not the whole answer.''
Dr. Irving Weissman, a stem-cell researcher and director of Stanford's Institute for Stem Cell Biology and Regenerative Medicine, agrees that the federal restrictions have impeded stem-cell work. He noted, for example, that analyzing the genes from new stem-cell lines cannot be done at federally funded facilities on the university campus.
http://www.mercurynews.com/mld/mercurynews/news/local/15080713.htmVeto rattles stem-cell efforts
Indeed, the only way to ensure that stem cell research across the United States is conducted in an ethical, regulated, and transparent fashion, and that allows U.S. scientists to lead, is to broaden federal support. As the National Academies reported in Stem Cells and the Future of Regenerative Medicine:
Human stem cell research that is publicly funded and conducted under established standards of open scientific exchange, peer review, and public oversight offers the most efficient and responsible means to fulfill the promise of stem cells to meet the need for regenerative medical therapies.
www.lifesciences.umich.edu/research/featured/aauletter.pdf
Association of American Universities